COSCIENS Biopharma (CSCI) Interest Expense

Annual Interest Expense

$96.60 K
+$800.00+0.84%

December 1, 2023

Summary

Performance

1-Year Change

+0.84%

3-Year Change

-29.69%

5-Year Change

+173.65%

15-Year Change

+89.41%

CSCI Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.98%
CSCI annual interest expense is higher than 17.98% of companies in Healthcare sector

High & Low

All-time High

$202.80 K
CSCI annual interest expense is currently -52.37% below its historical high of $202.80 thousand

3-Year Low

$95.80 K
CSCI annual interest expense is currently +0.84% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Annual Total Expenses

$22.51 M
CSCI annual total expenses is $22.51 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

Annual Cost Of Goods Sold

$4.20 M
CSCI annual cost of goods sold is $4.20 million

Annual Income Tax

-$900.60 K
CSCI annual income tax is -$900.60 thousand

Quarterly Interest Expense

$22.00 K
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+234.15%

3-Year Change

+234.15%

5-Year Change

+234.15%

CSCI Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.06%
CSCI quarterly interest expense is higher than 18.06% of companies in Healthcare sector

High & Low

All-time High

$56.70 K
CSCI quarterly interest expense is currently -61.20% below its historical high of $56.70 thousand

3-Year Low

-$16.40 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Quarterly Total Expenses

$6.71 M
CSCI quarterly total expenses is $6.71 million

Quarterly Operating Expenses

$5.79 M
CSCI quarterly total operating expenses is $5.79 million

Quarterly Cost Of Goods Sold

$914.00 K
CSCI quarterly cost of goods sold is $914.00 thousand

Quarterly Income Tax

-$112.00 K
CSCI quarterly income tax is -$112.00 thousand

TTM Interest Expense

$49.40 K
-$1000.00-1.98%

September 1, 2024

Summary

Performance

3-Month Change

-1.98%

1-Year Change

-11.15%

3-Year Change

-11.15%

5-Year Change

-11.15%

CSCI TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.06%
CSCI TTM interest expense is higher than 13.06% of companies in Healthcare sector

High & Low

All-time High

$195.90 K
CSCI TTM interest expense is currently -74.78% below its historical high of $195.90 thousand

3-Year Low

$49.40 K
CSCI TTM interest expense is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIexpensesmetrics:

Annual Total Expenses

$22.51 M
CSCI annual total expenses is $22.51 million

Annual Operating Expenses

$22.28 M
CSCI annual total operating expenses is $22.28 million

TTM Cost Of Goods Sold

$4.72 M
CSCI TTM cost of goods sold is $4.72 million

TTM Income Tax

-$1.37 M
CSCI TTM income tax is -$1.37 million

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

CSCI Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.8%+234.2%-11.2%
3 y3 years-29.7%+234.2%-11.2%
5 y5 years+173.7%+234.2%-11.2%

CSCI Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.9%+0.8%-24.1%+234.2%-58.9%at low
5 y5-year-37.4%+0.8%-42.0%+234.2%-68.0%at low
alltimeall time-52.4%+245.0%-61.2%+144.9%-74.8%+367.0%

COSCIENS Biopharma Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$22.00 K(0.0%)
$49.40 K(-2.0%)
Jun 2024
-
$22.00 K(+0.9%)
$50.40 K(-3.8%)
Mar 2024
-
$21.80 K(-232.9%)
$52.40 K(-5.8%)
Dec 2023
$96.60 K(+0.8%)
-$16.40 K(-171.3%)
$55.60 K(-42.7%)
Sep 2023
-
$23.00 K(-4.2%)
$97.10 K(+0.1%)
Jun 2023
-
$24.00 K(-4.0%)
$97.00 K(-1.0%)
Mar 2023
-
$25.00 K(-0.4%)
$98.00 K(-1.5%)
Dec 2022
$95.80 K(-19.6%)
$25.10 K(+9.6%)
$99.50 K(-3.8%)
Sep 2022
-
$22.90 K(-8.4%)
$103.40 K(-6.0%)
Jun 2022
-
$25.00 K(-5.7%)
$110.00 K(-5.1%)
Mar 2022
-
$26.50 K(-8.6%)
$115.90 K(-3.6%)
Dec 2021
$119.10 K(-13.3%)
$29.00 K(-1.7%)
$120.20 K(-6.9%)
Sep 2021
-
$29.50 K(-4.5%)
$129.10 K(-2.0%)
Jun 2021
-
$30.90 K(+0.3%)
$131.80 K(-1.0%)
Mar 2021
-
$30.80 K(-18.7%)
$133.10 K(-1.3%)
Dec 2020
$137.40 K(-11.0%)
$37.90 K(+17.7%)
$134.80 K(+0.2%)
Sep 2020
-
$32.20 K(0.0%)
$134.50 K(-4.7%)
Jun 2020
-
$32.20 K(-0.9%)
$141.10 K(-5.1%)
Mar 2020
-
$32.50 K(-13.6%)
$148.70 K(-3.6%)
Dec 2019
$154.30 K(+337.1%)
$37.60 K(-3.1%)
$154.30 K(+23.3%)
Sep 2019
-
$38.80 K(-2.5%)
$125.10 K(+31.8%)
Jun 2019
-
$39.80 K(+4.5%)
$94.90 K(+48.5%)
Mar 2019
-
$38.10 K(+353.6%)
$63.90 K(+82.1%)
Dec 2018
$35.30 K(-30.8%)
$8400.00(-2.3%)
$35.10 K(-42.8%)
Sep 2018
-
$8600.00(-2.3%)
$61.40 K(+7.5%)
Jun 2018
-
$8800.00(-5.4%)
$57.10 K(+7.3%)
Mar 2018
-
$9300.00(-73.2%)
$53.20 K(+5.8%)
Dec 2017
$51.00 K(+82.1%)
$34.70 K(+707.0%)
$50.30 K(+160.6%)
Sep 2017
-
$4300.00(-12.2%)
$19.30 K(-13.5%)
Jun 2017
-
$4900.00(-23.4%)
$22.30 K(-13.2%)
Mar 2017
-
$6400.00(+73.0%)
$25.70 K(-8.9%)
Dec 2016
$28.00 K
$3700.00(-49.3%)
$28.20 K(-14.5%)
Sep 2016
-
$7300.00(-12.0%)
$33.00 K(-8.3%)
DateAnnualQuarterlyTTM
Jun 2016
-
$8300.00(-6.7%)
$36.00 K(+27.7%)
Mar 2016
-
$8900.00(+4.7%)
$28.20 K(-27.7%)
Dec 2015
$38.00 K(-30.5%)
$8500.00(-17.5%)
$39.00 K(-310.8%)
Sep 2015
-
$10.30 K(+1960.0%)
-$18.50 K(-228.5%)
Jun 2015
-
$500.00(-97.5%)
$14.40 K(-79.6%)
Mar 2015
-
$19.70 K(-140.2%)
$70.60 K(+0.4%)
Dec 2014
$54.70 K(-3.2%)
-$49.00 K(-213.4%)
$70.30 K(-53.1%)
Sep 2014
-
$43.20 K(-23.8%)
$149.90 K(+31.5%)
Jun 2014
-
$56.70 K(+192.3%)
$114.00 K(+61.0%)
Mar 2014
-
$19.40 K(-36.6%)
$70.80 K(+1.0%)
Dec 2013
$56.50 K(-50.2%)
$30.60 K(+319.2%)
$70.10 K(-14.7%)
Sep 2013
-
$7300.00(-45.9%)
$82.20 K(-15.4%)
Jun 2013
-
$13.50 K(-27.8%)
$97.20 K(-12.6%)
Mar 2013
-
$18.70 K(-56.2%)
$111.20 K(-4.8%)
Dec 2012
$113.50 K(-35.9%)
$42.70 K(+91.5%)
$116.80 K(0.0%)
Sep 2012
-
$22.30 K(-18.9%)
$116.80 K(-14.7%)
Jun 2012
-
$27.50 K(+13.2%)
$137.00 K(-14.3%)
Mar 2012
-
$24.30 K(-43.1%)
$159.90 K(-12.8%)
Dec 2011
$177.10 K(-12.7%)
$42.70 K(+0.5%)
$183.40 K(-2.9%)
Sep 2011
-
$42.50 K(-15.7%)
$188.90 K(-3.6%)
Jun 2011
-
$50.40 K(+5.4%)
$195.90 K(+3.8%)
Mar 2011
-
$47.80 K(-0.8%)
$188.80 K(-3.3%)
Dec 2010
$202.80 K(+175.5%)
$48.20 K(-2.6%)
$195.30 K(+17.7%)
Sep 2010
-
$49.50 K(+14.3%)
$166.00 K(+23.1%)
Jun 2010
-
$43.30 K(-20.3%)
$134.90 K(+25.0%)
Mar 2010
-
$54.30 K(+187.3%)
$107.90 K(+55.5%)
Dec 2009
$73.60 K(+7.1%)
$18.90 K(+2.7%)
$69.40 K(-30.9%)
Sep 2009
-
$18.40 K(+12.9%)
$100.50 K(+22.4%)
Jun 2009
-
$16.30 K(+3.2%)
$82.10 K(-30.9%)
Mar 2009
-
$15.80 K(-68.4%)
$118.80 K(+0.7%)
Dec 2008
$68.70 K
$50.00 K(>+9900.0%)
$118.00 K(+73.5%)
Sep 2008
-
$0.00(-100.0%)
$68.00 K(0.0%)
Jun 2008
-
$53.00 K(+253.3%)
$68.00 K(+353.3%)
Mar 2008
-
$15.00 K
$15.00 K

FAQ

  • What is COSCIENS Biopharma annual interest expense?
  • What is the all time high annual interest expense for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual interest expense year-on-year change?
  • What is COSCIENS Biopharma quarterly interest expense?
  • What is the all time high quarterly interest expense for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly interest expense year-on-year change?
  • What is COSCIENS Biopharma TTM interest expense?
  • What is the all time high TTM interest expense for COSCIENS Biopharma?
  • What is COSCIENS Biopharma TTM interest expense year-on-year change?

What is COSCIENS Biopharma annual interest expense?

The current annual interest expense of CSCI is $96.60 K

What is the all time high annual interest expense for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual interest expense is $202.80 K

What is COSCIENS Biopharma annual interest expense year-on-year change?

Over the past year, CSCI annual interest expense has changed by +$800.00 (+0.84%)

What is COSCIENS Biopharma quarterly interest expense?

The current quarterly interest expense of CSCI is $22.00 K

What is the all time high quarterly interest expense for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly interest expense is $56.70 K

What is COSCIENS Biopharma quarterly interest expense year-on-year change?

Over the past year, CSCI quarterly interest expense has changed by +$38.40 K (+234.15%)

What is COSCIENS Biopharma TTM interest expense?

The current TTM interest expense of CSCI is $49.40 K

What is the all time high TTM interest expense for COSCIENS Biopharma?

COSCIENS Biopharma all-time high TTM interest expense is $195.90 K

What is COSCIENS Biopharma TTM interest expense year-on-year change?

Over the past year, CSCI TTM interest expense has changed by -$6200.00 (-11.15%)